Iron deficiency upregulates Egr1 expression
Tóm tắt
Iron-deficient anemia is a prevalent disease among humans. We searched for genes regulated by iron deficiency and its regulated mechanism. cDNA microarrays were performed using Hepa1c1c7 cells treated with 100 μM desferrioxamine (DFO), an iron chelator. Early growth response 1 (Egr1) was upregulated with at least 20-fold increase within 4 h and lasted for 24 h, which was confirmed by qRT-PCR. This activation was not seen by ferric ammonium citrate (FAC). DFO increased the transcriptional activity of Egr1-luc (−604 to +160) and serum response element (SRE)-luc reporters by 2.7-folds. In addition, cycloheximide lowered DFO-induced Egr1 mRNA levels. The upregulation of Egr1 by DFO was accompanied by sustained ERK signals along with phosphorylation of Elk-1. The ERK inhibitor (PD98059) prevented the DFO-induced Egr1 mRNAs. Overexpression of Elk-1 mutant (pElk-1S383A) decreased Egr1 reporter activity. DFO lowered reactive oxygen species (ROS) production and increased caspase 3/7 activity and cell death. DFO-induced iron deficiency upregulates Egr1 in part through transcriptional activation via ERK and Elk-1 signals, which may be important in the regulation of cell death in hepatoma cells. Our study demonstrated that iron depletion controlled the expression of Egr1, which might contribute to decisions about cellular fate in response to iron deficiency.
Tài liệu tham khảo
Akutagawa O et al (2008) Early growth response-1 mediates downregulation of telomerase in cervical cancer. Cancer Sci 99(7):1401–1406
Casey JL et al (1988) Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 240(4854):924–928
Cavigelli M et al (1995) Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14(23):5957–5964
Chan DA et al (2002) Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 277(42):40112–40117
Collins JF et al (2005) Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am J Physiol Gastrointest Liver Physiol 288(5):G964–G971
de Belle I et al (1999) p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene 18(24):3633–3642
Ganz T, Nemeth E (2006) Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 1763(7):690–699
Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434–1443
Gashler A, Sukhatme VP (1995) Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50:191–224
Gille H, Sharrocks AD, Shaw PE (1992) Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358(6385):414–417
Hao MW et al (2002) Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 8(2):203–207
Hasan RN, Schafer AI (2008) Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-kappaB. Circ Res 102(1):42–50
Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117(3):285–297
Huang RP et al (1994) Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 9(5):1367–1377
Huang RP et al (1995) Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 55(21):5054–5062
Huang RP et al (1998a) Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2. Int J Cancer. J Int Cancer 77(6):880–886
Huang RP et al (1998b) Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2. Int J Cancer 77(6):880–886
Johansen FE, Prywes R (1995) Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim Biophys Acta 1242(1):1–10
Kautz L et al (2008) Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112(4):1503–1509
Kuster GM et al (2005) Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111(9):1192–1198
Le NT, Richardson DR (2002) The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603(1):31–46
Lee SM, Vasishtha M, Prywes R (2010) Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem 285(29):22036–22049
Liu C, Adamson E, Mercola D (1996) Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc Natl Acad Sci USA 93(21):11831–11836
Liu C et al (1998) Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5(1):3–28
Loguinov AV, Mian IS, Vulpe CD (2004) Exploratory differential gene expression analysis in microarray experiments with no or limited replication. Genome Biol 5(3):R18
McMahon SB, Monroe JG (1995) A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor cross-linking in B lymphocytes. Mol Cell Biol 15(2):1086–1093
Mo Y et al (2000) Structure of the elk-1-DNA complex reveals how DNA-distal residues affect ETS domain recognition of DNA. Nat Struct Biol 7(4):292–297
Muthukkumar S et al (1995) Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol Cell Biol 15(11):6262–6272
Nishi H, Nishi KH, Johnson AC (2002) Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 62(3):827–834
Organization WH (2008) Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. World Health Organization, Geneva
Pagel JI, Deindl E (2011) Early growth response 1–a transcription factor in the crossfire of signal transduction cascades. Indian J Biochem Biophys 48(4):226–235
Said HM et al (2009) Egr-1 is not upregulated in response to hypoxic and oxygenation conditions in human glioblastoma in vitro. Mol Med Reports 2(5):757–763
Scharnhorst V et al (2000) EGR-1 enhances tumor growth and modulates the effect of the Wilms’ tumor 1 gene products on tumorigenicity. Oncogene 19(6):791–800
Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20(19):2390–2400
Templeton DM, Liu Y (2003) Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 1619(2):113–124
Wang J, Pantopoulos K (2011) Regulation of cellular iron metabolism. Biochem J 434(3):365–381
Wasylyk B, Hagman J, Gutierrez-Hartmann A (1998) Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 23(6):213–216
Wauson EM et al (2013) Off-target effects of MEK inhibitors. Biochemistry 52(31):5164–5166
White K, Munro HN (1988) Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J Biol Chem 263(18):8938–8942
Wu KJ, Polack A, Dalla-Favera R (1999) Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283(5402):676–679
Yang SH et al (1998) The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol Cell Biol 18(2):710–720
Yordy JS, Muise-Helmericks RC (2000) Signal transduction and the Ets family of transcription factors. Oncogene 19(55):6503–6513
Zhang DL et al (2009) A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 9(5):461–473
Zins K et al (2014) Egr-1 upregulates Siva-1 expression and induces cardiac fibroblast apoptosis. Int J Mol Sci 15(1):1538–1553